Evidence map›Paper›PMID 22436147›Full record

Trial reportBMC infectious diseases2012

CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection.

Aase B Andersen, Nyagosya S Range, John Changalucha, George Praygod, Jeremiah Kidola, Daniel Faurholt-Jepsen, Henrik Krarup, Harleen M S Grewal, Henrik Friis

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC infectious diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00311298 (The Role of Nutritional Support and Diabetes During Treatment of Pulmonary TB), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00311298 phase3completednot on this map

The Role of Nutritional Support and Diabetes During Treatment of Pulmonary TB: Two Randomized Nutritional Supplementation Trials in Tanzania

TypeinterventionalSponsorUniversity of CopenhagenRan2006 to 2009Enrolled1,250ConditionsTuberculosis, HIV, DiabetesArmsMultimicronutrients, Energy and proteins
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Aase B AndersenDepartment of Infectious Diseases, Odense University Hospital, University of Southern Denmark, Odense C, Denmark. aase.bengaard.andersen@ouh.regionsyddanmark.dk
Nyagosya S Range
John Changalucha
George Praygod
Jeremiah Kidola
Daniel Faurholt-Jepsen
Henrik Krarup
Harleen M S Grewal
Henrik Friis
National Institute for Medical Research · TZUniversity of Copenhagen · DKAalborg University Hospital · DKHaukeland University Hospital · NORegion of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe interaction of HIV and tuberculosis (TB) on CD4 levels over time is complex and has been divergently reported.

methodsCD4 counts were assessed from time of diagnosis till the end of TB treatment in a cohort of pulmonary TB patients with and without HIV co-infection and compared with cross-sectional data on age- and sex-matched non-TB controls from the same area.

resultsOf 1,605 study participants, 1,250 were PTB patients and 355 were non-TB controls. At baseline, HIV was associated with 246 (95% CI: 203; 279) cells per μL lower CD4 counts. All PTB patients had 100 cells per μL lower CD4 counts than the healthy controls. The CD4 levels were largely unchanged during a five-month of TB treatment. HIV infected patients not receiving ART at any time and those already on ART at baseline had no increase in CD4 counts after 5 months of TB treatment, whereas those prescribed ART between baseline and 2 months, and between 2 and 5 months increased by 69 (22;117) and 110 (52; 168) CD4 cells per μL after 5 months.

conclusionsThe increase in circulating CD4 levels observed in PTB in patients is acquired after 2 months of treatment irrespective of HIV status. Initiation of ART is the strongest factor correlated with CD4 increase during TB treatment. TRIAL REGISTRATION NUMBER: Clinical trials.gov: NCT00311298.

Indexed as

CD4 Lymphocyte CountAdultAntitubercular AgentsCase-Control StudiesCD4-Positive T-LymphocytesCohort StudiesCoinfectionFemaleHIV InfectionsHumansMaleMiddle AgedTanzaniaTuberculosis, PulmonaryYoung AdultAntitubercular Agents

Identifiers

PMID22436147
PMCPMC3383481
OpenAlexW2133369069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.